$ACAN
AmeriCann, Inc. Stock $acan

$acan Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-K Financial Statement

#000143774921027906 Filed on December 06, 2021

Income Statement

Concept	2021 Q3	2021	2020 Q3
Revenue	$735.1K	$2.029M	$287.6K
YoY Change	155.63%	302.88%	2387.54%
Cost Of Revenue	$38.15K	$38.15K
YoY Change		69.55%
Gross Profit	$696.9K	$1.990M
YoY Change		313.79%
Gross Profit Margin	94.81%	98.12%
Selling, General & Admin	$439.1K	$1.946M	$895.7K
YoY Change	-50.97%	182.02%	-55.56%
% of Gross Profit	63.01%	97.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$112.5K	$450.5K	$112.8K
YoY Change	-0.27%	0.82%	48934.78%
% of Gross Profit	16.14%	22.64%
Operating Expenses	$439.1K	$1.946M	$895.7K
YoY Change	-50.97%	191.52%	-55.56%
Operating Profit	$257.8K	$44.29K
YoY Change		-123.74%
Interest Expense	-$215.4K	-$907.2K	-$209.7K
YoY Change	2.71%	73.53%	-22.59%
% of Operating Profit	-83.53%	-2048.13%
Other Income/Expense, Net		-$907.2K
YoY Change		73.53%
Pretax Income	$42.44K	-$862.9K	-$817.8K
YoY Change	-105.19%	21.65%	-74.85%
Income Tax
% Of Pretax Income
Net Earnings	$42.44K	-$862.9K	-$817.8K
YoY Change	-105.19%	21.65%	-74.85%
Net Earnings / Revenue	5.77%	-42.54%	-284.38%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share	$1.754K	-$36.15K	-$34.79K
COMMON SHARES
Basic Shares Outstanding	24.20M	23.87M
Diluted Shares Outstanding		23.87M

Balance Sheet

Concept	2021 Q3	2021	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$696.4K	$696.4K	$183.0K
YoY Change	280.51%	280.51%	-60.71%
Cash & Equivalents	$696.4K	$696.4K	$183.0K
Short-Term Investments
Other Short-Term Assets	$22.96K	$22.96K	$12.65K
YoY Change	81.5%	81.5%	-98.59%
Inventory
Prepaid Expenses
Receivables	$258.9K	$258.9K	$124.6K
Other Receivables	$41.57K	$41.57K	$37.16K
Total Short-Term Assets	$1.020M	$1.020M	$357.4K
YoY Change	185.29%	185.3%	-74.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.00M	$14.00M	$7.512M
YoY Change	86.38%	-2.94%	-0.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$14.04M	$14.04M	$14.51M
YoY Change	-3.2%	-3.2%	40.07%
TOTAL ASSETS
Total Short-Term Assets	$1.020M	$1.020M	$357.4K
Total Long-Term Assets	$14.04M	$14.04M	$14.51M
Total Assets	$15.06M	$15.06M	$14.87M
YoY Change	1.33%	1.33%	26.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$97.50K	$97.50K	$65.00K
YoY Change	50.0%	50.0%	-75.5%
Accrued Expenses	$64.63K	$64.63K	$77.62K
YoY Change	-16.74%	-16.74%	-36.31%
Deferred Revenue
YoY Change
Short-Term Debt	$150.0K	$150.0K	$150.3K
YoY Change	-0.17%	-0.17%	-60.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$514.3K	$514.3K	$589.6K
YoY Change	-12.78%	-12.78%	-24.53%
LONG-TERM LIABILITIES
Long-Term Debt	$4.812M	$4.812M	$4.160M
YoY Change	15.67%	15.67%	-14.65%
Other Long-Term Liabilities	$4.228M	$4.228M	$4.243M
YoY Change	-0.36%	-0.36%
Total Long-Term Liabilities	$9.040M	$9.040M	$8.403M
YoY Change	7.58%	7.58%	72.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$514.3K	$514.3K	$589.6K
Total Long-Term Liabilities	$9.040M	$9.040M	$8.403M
Total Liabilities	$9.554M	$9.554M	$8.993M
YoY Change	6.24%	6.24%	59.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.59M		-$18.72M
YoY Change	4.61%		3.94%
Common Stock	$2.420K		$2.370K
YoY Change	2.11%		0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.510M	$5.510M	$5.873M
YoY Change
Total Liabilities & Shareholders Equity	$15.06M	$15.06M	$14.87M
YoY Change	1.33%	1.33%	26.35%

Cashflow Statement

Concept	2021 Q3	2021	2020 Q3
OPERATING ACTIVITIES
Net Income	$42.44K	-$862.9K	-$817.8K
YoY Change	-105.19%	21.65%	-74.85%
Depreciation, Depletion And Amortization	$112.5K	$450.5K	$112.8K
YoY Change	-0.27%	0.82%	48934.78%
Cash From Operating Activities	$148.1K	-$275.2K	-$46.42K
YoY Change	-419.0%	-153.08%	-95.88%
INVESTING ACTIVITIES
Capital Expenditures	-$58.72K	-$93.40K	-$5.840K
YoY Change	905.48%	-75.83%	-99.51%
Acquisitions
YoY Change
Other Investing Activities	$9.280K	$34.76K	$7.760K
YoY Change	19.59%	18.84%	29.12%
Cash From Investing Activities	-$49.44K	-$58.64K	$1.920K
YoY Change	-2675.0%	-83.59%	-100.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-300.0K	$847.0K	150.0K
YoY Change	-300.0%	-167.22%	-95.82%
NET CHANGE
Cash From Operating Activities	148.1K	-$275.2K	-46.42K
Cash From Investing Activities	-49.44K	-$58.64K	1.920K
Cash From Financing Activities	-300.0K	$847.0K	150.0K
Net Change In Cash	-201.4K	$513.2K	105.5K
YoY Change	-290.86%	-146.7%	-91.79%
FREE CASH FLOW
Cash From Operating Activities	$148.1K	-$275.2K	-$46.42K
Capital Expenditures	-$58.72K	-$93.40K	-$5.840K
Free Cash Flow	$206.8K	-$181.8K	-$40.58K
YoY Change	-609.61%	-120.09%	-172.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24196310
CY2021Q3	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	4303	USD
CY2020Q3	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	26246	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	269506	USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	571483	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24196310
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24196310
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23696310
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23696310
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	696380	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	183009	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9989	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10150	USD
CY2021Q3	acan	Tenant Receivable Current TenantReceivableCurrent	258854	USD
CY2020Q3	acan	Tenant Receivable Current TenantReceivableCurrent	124617	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12970	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2500	USD
CY2021Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	41564	USD
CY2020Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	37165	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	1019757	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	357441	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6846476	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6914080	USD
CY2021Q3	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	43185	USD
CY2020Q3	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	82347	USD
CY2021Q3	us-gaap	Assets Assets	15064702	USD
CY2020Q3	us-gaap	Assets Assets	14866289	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190020	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	276155	USD
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	97500	USD
CY2020Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	65000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	54194	USD
CY2020Q3	us-gaap	Interest Payable Current InterestPayableCurrent	72895	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12128	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20571	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10432	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4728	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	150000	USD
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	150250	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	514274	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	589599	USD
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	4230494	USD
CY2020Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	3578517	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	581646	USD
CY2020Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	581646	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4227878	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4243224	USD
CY2021Q3	us-gaap	Liabilities Liabilities	9554292	USD
CY2020Q3	us-gaap	Liabilities Liabilities	8992986	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	2420	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	2370	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25093435	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1761675	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24593485	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19585445	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18722552	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	5510410	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	5873303	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15064702	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14866289	USD
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	2028551	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	503512	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	38149	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	22500	USD
CY2021	us-gaap	Gross Profit GrossProfit	1990402	USD
CY2020	us-gaap	Gross Profit GrossProfit	481012	USD
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	42417	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	38179	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	311288	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	405920	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1592404	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1985142	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1761675	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	1946109	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	667566	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	44293	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-186554	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	18305	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	333681	USD
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	873143	USD
CY2020	us-gaap	Interest Expense Other InterestExpenseOther	760704	USD
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	52348	USD
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	95766	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-907186	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-522789	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-862893	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-709343	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23867543
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23504820
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	6110676	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	381970	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	90000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-709343	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	5873303	USD
CY2021	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	500000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-862893	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	5510410	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-862893	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-709343	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	450537	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	446854	USD
CY2021	acan	Operating Lease Rightofuse Asset Amortization Expense OperatingLeaseRightofuseAssetAmortizationExpense	67604	USD
CY2020	acan	Operating Lease Rightofuse Asset Amortization Expense OperatingLeaseRightofuseAssetAmortizationExpense	66877	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	381970	USD
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	90000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	304727	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	311370	USD
CY2021	acan	Increase Decrease In Tenant Receivable IncreaseDecreaseInTenantReceivable	134237	USD
CY2020	acan	Increase Decrease In Tenant Receivable IncreaseDecreaseInTenantReceivable	113053	USD
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	USD
CY2020	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	1761675	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	10470	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-14242	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-86135	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10879	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9642	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8917	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	32500	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	65000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	3242	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-62950	USD
CY2021	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	-21943	USD
CY2020	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	13962	USD
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8443	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	11442	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-275153	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	518333	USD
CY2021	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	93400	USD
CY2020	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	-0	USD
CY2021	acan	Payments To Acquire Property Plant And Equipment Excluding Construction In Progress PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress	-0	USD
CY2020	acan	Payments To Acquire Property Plant And Equipment Excluding Construction In Progress PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress	386487	USD
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	34763	USD
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	29251	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58637	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-357236	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	800000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	USD
CY2021	acan	Proceeds From Warrant Exercises Net ProceedsFromWarrantExercisesNet	500000	USD
CY2020	acan	Proceeds From Warrant Exercises Net ProceedsFromWarrantExercisesNet	0	USD
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1175000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	453000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	235000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	847000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1260000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	513210	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1098903	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	193159	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1292062	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	706369	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	193159	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	639466	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	594088	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6980957	USD
CY2014Q1	acan	Ownership Percentage Transfered OwnershipPercentageTransfered	0.93	pure
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.</p>
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Concentration of Credit Risks and Significant Customers</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivable, deposits tenant receivables and notes receivable. We place our cash with high credit quality financial institutions. As of <em style="font: inherit;"> September 30, 2021 </em>and <em style="font: inherit;">2020,</em> we had outstanding notes receivable of $84,749 and $119,512, respectively and tenant receivables of $258,854 and $124,617, respectively, with BASK, Inc. ("BASK"), a related party.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">For the year ended <em style="font: inherit;"> September 30, 2021, </em>all of the Company’s revenue was earned from one customer, BASK.</p>
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7960427	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7960427	USD
CY2021	us-gaap	Depreciation Depreciation	450537	USD
CY2020	us-gaap	Depreciation Depreciation	446854	USD
CY2021Q3	acan	Property Lease Unearned Revenue PropertyLeaseUnearnedRevenue	0	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q3	acan	Working Capital Deficit WorkingCapitalDeficit	505483	USD
CY2020Q3	acan	Working Capital Deficit WorkingCapitalDeficit	-232158	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19585445	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18722552	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-862893	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	696380	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	183009	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9989	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10150	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	706369	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	193159	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3586062	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2838966	USD
CY2021Q3	acan	Notes And Other Receivables Net NotesAndOtherReceivablesNet	84749	USD
CY2020Q3	acan	Notes And Other Receivables Net NotesAndOtherReceivablesNet	119512	USD
CY2021Q3	acan	Notes And Other Receivables Net Current NotesAndOtherReceivablesNetCurrent	41564	USD
CY2020Q3	acan	Notes And Other Receivables Net Current NotesAndOtherReceivablesNetCurrent	37165	USD
CY2021Q3	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	43185	USD
CY2020Q3	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	82347	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-862893	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-709343	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23867543
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23504820
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23867543
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23504820
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3586062	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2838966	USD
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q3	acan	Deferred Tax Assets Temporary Difference Net Operating Loss DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss	862893	USD
CY2021Q3	acan	Deferred Tax Assets Tax Effect Net Operating Loss DeferredTaxAssetsTaxEffectNetOperatingLoss	266720	USD
CY2020Q3	acan	Deferred Tax Assets Temporary Difference Net Operating Loss DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss	709343	USD
CY2020Q3	acan	Deferred Tax Assets Tax Effect Net Operating Loss DeferredTaxAssetsTaxEffectNetOperatingLoss	174144	USD
CY2021Q3	acan	Deferred Tax Assets Temporary Difference Tax Impact True Up DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp	0	USD
CY2021Q3	acan	Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect	0	USD
CY2020Q3	acan	Deferred Tax Assets Temporary Difference Tax Impact True Up DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp		USD
CY2020Q3	acan	Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect	20927	USD
CY2021Q3	acan	Deferred Tax Assets Temporary Difference Other DeferredTaxAssetsTemporaryDifferenceOther	-507485	USD
CY2021Q3	acan	Deferred Tax Assets Other Temporary Difference Tax Effect DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect	-156864	USD
CY2020Q3	acan	Deferred Tax Assets Temporary Difference Other DeferredTaxAssetsTemporaryDifferenceOther	835040	USD
CY2020Q3	acan	Deferred Tax Assets Other Temporary Difference Tax Effect DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect	205002	USD
CY2021Q3	acan	Deferred Tax Assets Temporary Difference Gross DeferredTaxAssetsTemporaryDifferenceGross	355408	USD
CY2021Q3	acan	Deferred Tax Assets Tax Effect Gross DeferredTaxAssetsTaxEffectGross	109856	USD
CY2020Q3	acan	Deferred Tax Assets Temporary Difference Gross DeferredTaxAssetsTemporaryDifferenceGross	1544383	USD
CY2020Q3	acan	Deferred Tax Assets Tax Effect Gross DeferredTaxAssetsTaxEffectGross	400073	USD
CY2021Q3	acan	Deferred Tax Assets Temporary Difference Valuation Allowance DeferredTaxAssetsTemporaryDifferenceValuationAllowance	355408	USD
CY2021Q3	acan	Deferred Tax Assets Tax Effect Valuation Allowance DeferredTaxAssetsTaxEffectValuationAllowance	109856	USD
CY2020Q3	acan	Deferred Tax Assets Temporary Difference Valuation Allowance DeferredTaxAssetsTemporaryDifferenceValuationAllowance	1544383	USD
CY2020Q3	acan	Deferred Tax Assets Tax Effect Valuation Allowance DeferredTaxAssetsTaxEffectValuationAllowance	400073	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11919394	USD
CY2020Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11564017	USD
CY2021Q3	acan	Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences	109857	USD
CY2020Q3	acan	Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences	379146	USD
CY2021	acan	Deferred Tax Assets Valuation Allowance Percent Offset DeferredTaxAssetsValuationAllowancePercentOffset	1	pure
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-747096	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-400073	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0991	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0355	pure
CY2021	acan	Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent	0.3091	pure
CY2020	acan	Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent	0.2455	pure
CY2021	acan	Effective Income Tax Rate Reconciliation Net Operating Loss Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent	-0.3091	pure
CY2020	acan	Effective Income Tax Rate Reconciliation Net Operating Loss Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent	-0.2455	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	acan	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	500000
CY2021	acan	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	500000
CY2021	acan	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.00
CY2020	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	191490
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	90000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1050000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.64
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.25
CY2020	acan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P5Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	200000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.50
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1850000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.99
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	150000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.50
CY2021	acan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm	P2Y6M
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1700000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.94
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1700000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.94
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y6M
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1700000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.94
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y6M
CY2020	acan	Class Of Warrant Or Right Forfeited During Period ClassOfWarrantOrRightForfeitedDuringPeriod	11238650
CY2020	acan	Class Of Warrant Or Right Forfeited During Period Exercise Price ClassOfWarrantOrRightForfeitedDuringPeriodExercisePrice	1.52
CY2020	acan	Class Of Warrant Or Right Forfeited Weighted Average Remaining Contract Term ClassOfWarrantOrRightForfeitedWeightedAverageRemainingContractTerm	P2Y3M18D
CY2020	acan	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	1600000
CY2020	acan	Class Of Warrant Or Right Expired During Period Exercise Price ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice	2.25
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9638650
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.00
CY2020	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P1Y9M18D
CY2021	acan	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	1472000
CY2021	acan	Class Of Warrant Or Right Expired During Period Exercise Price ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice	0
CY2021	acan	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	500000
CY2021	acan	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.00
CY2021	acan	Class Of Warrant Or Right Exercised Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisedWeightedAverageRemainingContractTerm	P1Y
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7666650
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.21
CY2021	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P0Y9M18D
CY2021Q3	acan	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	7666650
CY2021Q3	acan	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	1.21
CY2021	acan	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm	P0Y9M18D
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6980957	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4256869	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6846476	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10432	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4227878	USD
CY2021Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P45Y
CY2021Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.079	pure
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	341500	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	341500	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	341500	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	341500	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	341500	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13660001	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15367501	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11129191	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4238310	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10432	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4227878	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	429459	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	401021	USD

Files In Submission

Name	View Source	Status
0001437749-21-027906-index-headers.html	Edgar Link	pending
0001437749-21-027906-index.html	Edgar Link	pending
0001437749-21-027906.txt	Edgar Link	pending
0001437749-21-027906-xbrl.zip	Edgar Link	pending
acan-20210930.xsd	Edgar Link	pending
acan-20210930_cal.xml	Edgar Link	unprocessable
acan-20210930_def.xml	Edgar Link	unprocessable
acan-20210930_lab.xml	Edgar Link	unprocessable
acan-20210930_pre.xml	Edgar Link	unprocessable
acan20210930_10k.htm	Edgar Link	pending
acan20210930_10k_htm.xml	Edgar Link	completed
ex_310206.htm	Edgar Link	pending
ex_310207.htm	Edgar Link	pending
ex_310208.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACAN
AmeriCann, Inc. Stock $acan

2021 Q3 Form 10-K Financial Statement

#000143774921027906 Filed on December 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN AmeriCann, Inc. Stock $acan

2021 Q3 Form 10-K Financial Statement

#000143774921027906 Filed on December 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN
AmeriCann, Inc. Stock $acan